Becker Erica C, Grover Dheera, Patel Sanket, Dhakras Purabi, Rossi Lisa
Department of Internal Medicine, University of Connecticut Health Center, Farmington, CT.
Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA.
ACG Case Rep J. 2022 Nov 14;9(11):e00903. doi: 10.14309/crj.0000000000000903. eCollection 2022 Nov.
Although uncommon, pylephlebitis is a life-threatening complication of mesenteric vein thrombosis. It is reported to affect adult men more commonly than women, with a median age of 57 years. Furthermore, few cases have been reported of pylephlebitis in patients with inflammatory bowel disease. Owing to low prevalence, there is a paucity of data regarding the diagnosis and management of pylephlebitis. Treatment approach ranges from conservative management (antibiotics and/or systemic anticoagulation) to surgical management. We report a case of a 62-year-old man diagnosed with inflammatory bowel disease with a course complicated by pylephlebitis of the inferior mesenteric vein managed successfully with antibiotics and anticoagulation.
虽然罕见,但门静脉炎是肠系膜静脉血栓形成的一种危及生命的并发症。据报道,成年男性比女性更易受其影响,中位年龄为57岁。此外,炎症性肠病患者中门静脉炎的病例报道较少。由于发病率低,关于门静脉炎的诊断和管理的数据很少。治疗方法从保守治疗(抗生素和/或全身抗凝)到手术治疗不等。我们报告一例62岁男性,诊断为炎症性肠病,病程中并发肠系膜下静脉门静脉炎,通过抗生素和抗凝治疗成功治愈。